Clinical Trial Results:
"Estudio abierto, randomizado, controlado para comparar la eficacia, seguridad y tolerancia de la administración una vez cada cuatro semanas de C.E.R.A por vía subcutánea frente a darbepoetina alfa para el mantenimiento de las concentraciones de hemoglobina en pacientes receptores de trasplante renal con anemia renal crónica "
"An open label randomised controlled study to compare the efficacy, safety and tolerability of once each four weeks administration of subcutaneous C.E.R.A. versus darbepoetin alfa for the maintenance of haemoglobin levels in renal transplant recipients with chronic renal anaemia"
Summary
|
|
EudraCT number |
2007-001905-10 |
Trial protocol |
ES |
Global completion date |
31 Jul 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Oct 2016
|
First version publication date |
08 Oct 2016
|
Other versions |
|
Summary report(s) |
Clinicaltrials.gov Receipt |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.